Vincent P. Ippolito, EVP & Chief Commercial Officer at Anacor Pharmaceuticals, Inc. (ANAC), sold 19,800 shares at $95.29 ($1.9M) on 2016-01-19, disclosed to the SEC on 2016-01-21.
Open-market sale of $1.9M ANAC by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $93.92 | 1,200 | $113K | 6.0% |
| 2 | $95.29 | 13,300 | $1.3M | 67.1% |
| 3 | $96.00 | 5,300 | $509K | 26.9% |
| Total | $95.40 avg | 19,800 | $1.9M | 100% |
| Filing → |
| ANAC | SELL | 2016-01-21 | $1.9M | — | Filing → |
| ANAC | SELL | 2016-01-21 | $622K | — | Filing → |
| ANAC | SELL | 2016-01-05 | $62K | — | Filing → |